EXECUTIVE SUMMARY

Background
The program began in November 1995 when NORPLANT ® service provision was re-introduced in the five university hospitals that were included in the clinical trials. NORPLANT ® service was then introduced to more university hospitals and teaching hospitals. In November 1996, it was decided to expand NORPLANT ® services. The revised plan added the use of mobile teams, consisting of one physician and one nurse from university or teaching hospitals. These mobile teams visited MOHP health facilities according to predetermined schedules to provide one-day NORPLANT ® services.
substantially increased demand for NORPLANT ® insertions at these sites. The MOHP and FRONTIERS began discussing the need for investigating these service delivery aspects in 1999.
From those consultations this study emerged.
Study Objectives
The study has the following short-term objectives:
1. To assess the completeness and accuracy of the NORPLANT ® central level management information system (MIS) and client record cards, specifically related to the ability of the NORPLANT ® program to ensure the timely removal of expired NORPLANT ® implants.
2. To identify factors influencing provider attitudes and motivation to provide NORPLANT ® services.
3. To develop an understanding of NORPLANT ® users' perspectives of the method, including their satisfaction with the services they have received and their knowledge about the need for timely removal.
Study Methods
The study employed an observational cross-sectional analysis of settings where NORPLANT ® services are currently provided. It employed 4 types of data collection instruments and 2 types of research methods. An abbreviated audit of the client record system at selected facilities and an audit of the central level MOHP MIS of NORPLANT ® users were conducted. In addition, NORPLANT ® providers and users were interviewed.
The study compared information on clients obtained from the clinics' client records (in clinic registries and logbooks) to the actual client records available at the MOHP MIS central level to assess the reliability and completeness of the recording system and to check if information on the NORPLANT ® clients recorded in the health facility logbook was also included in the central level
MIS.
A Standardized questionnaire was produced for use with all consenting physicians and nurses who provided NORPLANT ® services at the study clinics, and who were available during the data collection period.
In addition, two categories of NORPLANT ® users were requested to give consent for interviews:
1. Women who came to the study sites during the data collection period to have NORPLANT ® inserted or to receive follow-up services within one month of insertion. These women were requested to consent to exit interviews. This group of women are referred to as "new users".
2. Women who began NORPLANT ® use between 1-4 years ago. These women were identified by their medical records and were contacted at their homes by the health care providers to ascertain if they would agree to an interview at the clinic or their home. This group of women are referred to as "continuing users".
The study was conducted in approximately one-third (36 sites in total) of the three types of health facilities providing services: MOHP, university and teaching hospitals, that were purposively chosen by a panel of experts.
The study instruments were pre-tested in five clinics that were not included in the study sites. Data 
Findings
For all study sites, the study collected data on the mean monthly NORPLANT ® caseload per clinic during the period August 1999 -September 2000 for both insertions and removals. The figures indicate that in general, for all the period shown, the monthly mean number of NORPLANT ® insertions per clinic is 11.3 and the median is 9.5 with a range of mean insertions of 1.8 -40.1.
Also, the monthly mean number of removals is 1.2 and the median is 0.1, with a range of removals of 0 -9.6.
The majority of the physicians providing NORPLANT ® services are male (62 percent) and more than one-half of them are 40 years old or more (mean age is about 41 years). More than 90 percent of the physicians have attained post-graduate degrees. Approximately 94 percent of the physicians who provide NORPLANT ® services have attended training courses on the insertion and removal of
The study findings indicated a lack of consensus among physicians about NORPLANT ® contraindications and suggest the need for more training of physicians on this issue. Also, physicians faced difficulties in NORPLANT ® removal. About two-fifths (43%) of physicians who had ever removed NORPLANT ® reported that the most frequent problems met were that the site of implanted capsules was not clear (36%) and the difficulty of removing all rods in one session (32%).
Although the majority of physicians reported that there is a system in place to follow-up clients who fail to make follow-up visits, about four-fifths of physicians (80%) reported that there is no mechanism in place to do home visits for those women. The implication is that women who may forget the removal date will not be contacted by clinic staff to be advised for removal.
The study findings indicated that about 10% of the new users had not previously used another method before NORPLANT ® . The IUD and injectables were used each by about one-third of the new NORPLANT ® users and the pill was used by about one-fourth of the women before they switched to NORPLANT ® .
This study also collected information on counseling and information given to clients by service providers before and after NORPLANT ® insertion. Almost all of the women (96%) reported being told about the use duration of NORPLANT ® , (i.e., five years). About two-thirds were told about NORPLANT ® advantages and one-half were told about NORPLANT ® insertion procedures.
However, counseling on potential side-effects was provided to only 39% of the women.
The majority reported being told about the need for follow-up visits (92%). However, only 85%
reported that they received a card including the schedule for follow-up visits. Only about one-fourth of women were told about the due date for removal before they left the clinic. In addition, about 69% of women were advised what to do in case they experienced side-effects.
The study examined the satisfaction with the NORPLANT ® method and related aspects of service provision received among new users. Almost all new clients (98%) reported that the insertion procedure went well and no problems were faced. About (74%) reported that they didn't feel pain or fear during the insertion procedure. Most (89%) of the new users who received a free method reported that they would still request NORPLANT ® insertion if they were asked to pay for it. About three-fourths (76%) of the new users who paid for the method reported that the payment made was reasonable (mean payment for the method was LE 16.9).
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The study also collected data on the experiences of continuing users (n=624) of NORPLANT ® (i.e., women who had NORPLANT ® inserted 1-4 years ago). The two most commonly cited advantages to NORPLANT ® use among this group are its long duration (36%) and fewer side effects (24%).
Some of the continuing users mentioned that they had less side-effects with NORPLANT ® or sideeffects that were more tolerable compared with other family planning methods that they tried before ).
An additional one-fourth mentioned that they had NORPLANT ® removed because of its other sideeffects. The decision to remove NORPLANT ® was primarily made by the woman herself (62%), while 29% of the women stated that the physician recommended removal.
Both NORPLANT ® continuers and discontinuers were asked about the duration of NORPLANT ® use since insertion. The study findings indicated that about one-half of woman who discontinued NORPLANT ® use had the implants removed before the second year of use. Overall, the average duration of NORPLANT ® use among continuers and discontinuers was 1.8 and 1.4 years, respectively.
Both continuing users and discontinuers were asked about side-effects experienced during NORPLANT ® use. As expected, substantially higher proportions of NORPLANT ® discontinuers reported experiencing NORPLANT ® side-effects compared to the continuers group. Among the discontinuers group the most frequently reported side-effects experienced were severe bleeding (47%), weight changes (39%), menstrual cycle disturbance (35%) and suffering continuous headache (28%). For the continuers group, the most frequently reported side-effects for NORPLANT ® were menstrual cycle disturbance (30%), amenorrhoea (18%) and weight changes (17%).
Women who had NORPLANT ® removed (n=103) did report some difficulties with the removal experience. About one-half of women said that the removal procedure was difficult (e.g. felt pain,
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Seventy-one percent of women who had NORPLANT ® removed switched to another family planning method after removal. Among this group, about 38% switched to the IUD, about 33%
switched to the pill, and about 26% switched to injectables.
Among all of the sample women who began using NORPLANT ® between 1-4 years ago, the vast majority reported general satisfaction with the method, and the services. About 80% reported having no felt pain or fear during the insertion procedure. Almost all women who reported that the rods were recognized by others in their arms (n=139) indicated that they were not annoyed because of that. About 90 percent of women who were still using NORPLANT ® intend to continue NORPLANT ® use to the end of the five-year duration. Almost two-thirds (61%) of all women stated that they would recommend NORPLANT ® to others. However, women who discontinued NORPLANT ® use (n=103) were less satisfied with the method. Only 42 percent of this group reported that they were comfortable with NORPLANT ® use and 28 percent said that they will recommend NORPLANT ® to others.
The study raised a number of recommendations. They addressed issues related to quality of care, program sustainability and the ability of MOHP MIS to track and locate women eligible for removal, including:
1. Provide further training to service providers involved in NORPLANT ® service provision.
Assessment of the specific training needs for quality NORPLANT ® service provision is needed.
2.
Promote accessibility to removal services and quality of these services.
3.
Develop adequate client follow-up systems to contact clients eligible for removal
4.
Develop an integrated quality oriented monitoring and evaluation system for NORPLANT ® service delivery sites.
5.
Reconsider the decision to provide NORPLANT ® free of charge, in view of the findings on women's readiness to pay for NORPLANT ® among the majority of women who received a free method to promote NORPLANT ® program sustainability. There are several critical elements to providing high quality NORPLANT ® services, including the following:
LIST OF TABLES
• the completeness of client records at the service delivery sites
• the maintenance and linkage of local and central level registries of users
• the capacity of local facilities to track and locate women who fail to return for removal, and providers' technical knowledge and attitudes about providing NORPLANT ® The MOHP and FRONTIERS began discussing the need for investigating these service delivery aspects in 1999. From those consultations this study emerged.
STUDY OBJECTIVES
Long-term Objective
This study will help ensure that providers offer NORPLANT ® in a balanced and culturally sensitive way with proper attention to safety and quality issues, and the needs of users.
Immediate Objectives
STUDY DESIGN
The study employed an observational cross-sectional analysis of settings where NORPLANT ® services are currently provided. NORPLANT ® providers (physicians and nurses) were interviewed, at the facility where they work. In addition two categories of NORPLANT ® users were requested to give consent for interviews:
1. Women who came to the study sites during the data collection period to have NORPLANT ® inserted or to receive follow-up services within one month of insertion. This group was requested to consent to exit interviews.
2. Women who began NORPLANT ® use between 1-4 years ago. These women were identified by their medical records and were contacted at their homes by the health care
providers to ascertain if they would agree to an interview at the clinic or their home. An abbreviated audit of the client record system at selected facilities and an audit of the central level MOHP MIS of NORPLANT ® users were conducted.
Study Instruments and Research Methods
The study employed 4 types of data collection instruments and 2 types of research methods.
Record system audit
The study compared information on clients obtained from the clinics' client records (in clinic registers and logbooks) to the actual client records available at the MOHP MIS central level to assess the completeness of the recording system, and to check if information on NORPLANT ® clients recorded in the health facility logbook was also included in the central level MIS. A review of the accuracy of the information was also conducted for client records that existed in both the clinic and the central MIS.
Provider interviews
A standardized questionnaire was produced for use with all consenting physicians and nurses who provided NORPLANT ® services at the study sites, and who were available during the data collection period.
Exit interviews
Standardized interviews were conducted with consenting women who had just received NORPLANT ® insertion at the study sites. Interviews were also conducted with women who came to the clinic for a follow-up visit after one month of insertion and had just received services and counseling. This group of women will be referred to as "new users" in the study findings sections.
Home interviews
Follow-up interviews were conducted with randomly selected women who had NORPLANT ® inserted between 1-4 years ago at facilities included in the study sample. This group of women will be referred to as "continuing users" in the study findings sections (keeping in mind that some of these women discontinued NORPLANT ® use later). clinics from teaching hospitals, yielding a total of 36 sites in the study.
Record system audit
Twenty client entries were selected randomly from the MIS for each of the study's 36 clinics. These entries were transcribed on the blank client record sheets 1 that MOHP clinics use to record information for women who have had NORPLANT ® inserted. Data collectors were instructed to locate data from client record sheets from the clinic registers/logbooks. For some clinics the total available MIS records were less than 20 cases. In these small caseload clinics all of the available records were used. The information collected from the clinics' registers/logbook was then compared with the information retrieved from the central MIS. Discrepancies were detected (both completely missing cases and cases with non-matching information). A form was developed that used an ordinal ranking of the fit between these two independent data sources and also of the degree of completeness of the information. The ranking classified each data item as either 0 (no fit) or 1 (perfect fit). 
Client follow-up card audit
During home interviews, each woman was asked if she has received a follow-up card from the clinic. The information recorded on the card (if available) was copied on a form that was designed for this purpose. The corresponding information from the clinic's registers was also copied on the same form. Information of these two sources was then matched in the office.
Monthly caseload and staffing information
A clinic form was designed to collect information from each of the study sites on the number and types of service providers, the number of service providers who received training on NORPLANT ® insertion/removal, the year that NORPLANT ® services were first provided, and the availability of client follow-up services and other information related to NORPLANT ® insertion and removal.
This form also abstracted data on NORPLANT ® monthly caseload (insertion/removal) from each clinic's logbook for the 14 month period of August 1999-September 2000.
Home interviews of continuing users
Women eligible for home interviews were defined as those women who had NORPLANT ® inserted between 1 to 4 years ago. Clinic staff (usually nurses) in each of the study's 36 sites were instructed in systematic random selection procedures to identify 18 client names from the clinic register/ logbook for a total of 648. Special forms were developed for recording locator information, (the woman's name, her husband's name and her address). Due to inaccuracies in addresses and other difficulties in locating the woman (even if the address was correct), additional women were randomly selected to reach the target number of home interviews. A total of 624 home interviews were completed out of 1,125 randomly selected clients (55 percent) (see Table 2 ). The majority of clients included in the sample of home interviews were women who had NORPLANT ® inserted less than two years ago (because of the lack of information in clinic registers on women who had NORPLANT ® inserted more than two years ago).
However, due to incomplete logbooks, missing addresses, and the unavailability of logbooks in some clinics for more than two years, it was necessary to include in this sample some women who had NORPLANT ® inserted less than 12 months ago to achieve the target sample. For this latter group (n= 174), the mean duration of insertion is 8.4 months and the median is 10 months. Clinic staff (usually the Raida or the nurse) approached the women selected for home interviews to obtain their informed consent. Consenting women were given the option of either visiting the health facility to meet with the female interviewer or conducting the interview at home, at their
convenience.
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Exit Interviews
All eligible NORPLANT ® users were contacted after they had received services and were asked to give consent for an interview. This process continued in each clinic until 20 clients were interviewed.
Data Collection Procedures
Pre-test of the study instruments
The study instruments were pre-tested in five clinics that were not included in the study sites. The pre-test training lasted for three days. Two teams were involved in the pre-test activities for one 
Field work
Thirteen data collection teams, each consisting of one male supervisor and two to four female interviewers (based on the number of clinics assigned to each team) were formed. Each team was assigned to work in one or two governorates. One interviewer was assigned to a study site. The interviewer was responsible for conducting client exit interviews, home interviews (for clients who received NORPLANT ® service at this clinic) and provider interviews. In addition, the interviewer was responsible for completing the information sheets on client cards. Based on client caseload information and the target number of interviews, each interviewer was instructed to stay between two to four weeks at the clinic to collect data needed.
The supervisor was responsible for organizing the teamwork; field editing of the completed forms and making sure that the target sample was achieved. In addition, the supervisor was responsible for completing the clinic form. Due to variability in caseload between clinics, gathering the target number of 20 exit interviews for some clinics was difficult. Therefore, data collection was extended in some clinics for an additional week.
Quality control measures were applied throughout the data collection period including the close supervision of data collection procedures. The principle investigator, research coordinator, Table 3 shows the number of study instruments completed by type of health facility. A u g 1 9 9 9 S e p t 1 9 9 9 O c t 1 9 9 9 N o v 1 9 9 9 D e c 1 9 9 9 J a n 2 0 0 0 Selected Socio-demographic Characteristics of Physicians Table 5 presents the findings on socio-demographic characteristics of the physicians who provide NORPLANT ® services in the study sites. The majority of the physicians are male (62 percent) and more than one-half of them are 40 years old or more (mean age is about 41 years). More than 90 percent of the physicians have attained post-graduate degrees (diploma, master or doctorate degree).
FINDINGS Clinics Characteristics
In fact, all the university and teaching hospital physicians have attained post-graduate degrees, indicating a high education level overall among physicians who provide NORPLANT ® services.
On average university hospital physicians have worked about six years in providing NORPLANT ® services compared to about three years for teaching hospitals physicians and a year and half for MOHP physicians.
An Assessment of the Egyptian NORPLANT ® Program Physicians were asked about the training they received in family planning and reproductive health as well as in NORPLANT ® insertion and removal. They were also asked if they thought that the training they received in NORPLANT ® insertion and removal was sufficient. Almost all the physicians indicated that they received training in family planning and reproductive health areas.
Approximately 94 percent of the physicians who provide NORPLANT ® services have attended training courses on the insertion and removal of NORPLANT ® but physicians in teaching hospitals were less likely to be fully trained. Overall about one-half of the physicians who provide NORPLANT ® reported a felt need for additional training in NORPLANT ® removal. Table 7 presents data on selected demographic and socio-economic characteristics of new and continuing users of NORPLANT ® obtained through exit interviews and home visits (respectively).
Selected Socio-Demographic Characteristics of Nurses
The data show that new users are on average younger (mean age = 31.4 years) than continuing users (mean age = 34.3 years) and the difference is significant (p<0.05). Both groups of women had nearly the same mean number of living children (slightly more than four). On average, the mean age of youngest child was 2.8 years for new users which is significantly lower than the mean age of 4.8 years for continuing users (the difference is significant, p<0.05).
It should be noted that the study findings reflected a higher percentage of women who use NORPLANT ® for spacing purposes among new users (14 percent) than continuing users (only 9 percent) (not shown in the table). This may explain the difference in the mean age of youngest child. In addition, the mean age of youngest child for the continuing users refers to date of interview rather than date of insertion. 
Client Record System Audit
The study compared information on clients obtained from the clinics' client records (in clinic registries and log books) to the actual client records available at the MOHP MIS central level to assess the reliability and completeness of the recording system. Source: client exit and home interviews 1. Differences are significant (P<0.05) 2. A composite index for socio-economic status of the household. It includes a set of variables related to housing conditions and ownership of consumer durables of the woman's household. The housing conditions included in the index and their scoring are as follows: one point for each room in the household; one point for piped drinking water, modern flush toilet, electricity and a cement/ cement tile floor; and two points if the floor material was wood parquets, ceramic tiles, marble or wall-to-wall carpet. In addition, one point was given for ownership of each of the following items: a radio with cassette recorder; a black and white television; a color television; a video; a telephone; an electric fan; a water heater, a refrigerator, a washing machine, a bicycle, a private car/ motorcycle, transport equipment, farm or other land and livestock. Based on data of exit and home interviews, the value of this index ranged between 2-25 
Accuracy of client records information between clinic and central MIS
A review of accuracy of the information was conducted for client records that existed in both the 
Accuracy of the clients' addresses
Each facility that provides NORPLANT ® should keep complete and correct information about the clients' addresses and the addresses of one of their relatives in order to ensure follow-up care, including removal of the implants. The availability of this information is critical for clients who fail to return to clinics for removal at the end of NORPLANT ® use duration. Table 2 (presented earlier) indicates that only about 56 percent of the continuing users selected at random for the home interview were actually reached using the locator information on the client records. An additional 37 percent of NORPLANT ® clients could not be located because their addresses were incomplete.
Furthermore, in the majority of clients' records information on the relative's address was not collected. In only 3 percent of the cases the address was complete and correct but it was not
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Existence of the clients' cards
The they did not receive a card. Cases in which the card was available also indicated some discrepancies in accuracy of information recorded on the card, but overall the information on the client card corresponded with the clinic records particularly on the year of insertion. and that it is a safe and effective method (61 percent) (Figure 4 ). About one-half of physicians mentioned that women do not need to remember doing anything to avoid pregnancy, like taking a pill daily. The most frequently reported disadvantage of NORPLANT ® is that it causes menstrual cycle disturbance (reported by 62% of physicians) (see Figure 5 ). The next most frequently mentioned disadvantage is that it sometimes 
Percent of physicians indicating disadvantage
causes severe bleeding (42%), followed by difficulty of removal (36%). Other disadvantages mentioned were NORPLANT ® causes severe headache (27%), pain at site of insertion (14%), weight gain (9%) and that its insertion and removal required a surgical procedure (12%). In a separate question (results not shown in Figure 5 Table 9 ).
There appears to be an overreliance on this system, when physicians were asked about what happens if a woman doesn't visit the clinic for her due follow-up visit, about four-fifths of physicians (80%) reported that there is no mechanism in place to do home visits for those women. This means that women who may forget due removal date/end of NORPLANT ® effective use duration will not be contacted by clinic staff to be advised for removal. About one-tenth of physicians, however, reported that usually the clinic sends a Raida (community outreach worker) to the woman's home to remind her about the due follow-up visit. . About one-fourth of the physicians reported that they ask the woman to come to the clinic later (another day) when NORPLANT ® will be available. About 14% of the physicians, however, reported that they refer the woman to another clinic, if they think NORPLANT ® supplies are available there.
Promotion of NORPLANT ®
This study examined how NORPLANT ® are promoted or encouraged (see Figure 12 ). Service providers were asked a set of questions on whether or not they receive cash incentives for for nurses LE 84 (not shown). In general, for all physicians and nurses interviewed, the majority report that monetary incentives could contribute to increase NORPLANT ® insertion caseload (80% of physicians and 67% of nurses).
It may be noted here that, according to MOHP policy for incentives, women requesting NORPLANT ® insertion were originally asked to pay LE 20 for the method. This amount was distributed among service providers working in NORPLANT ® services. However, as indicated earlier, MOHP is now offering NORPLANT ® free of charge, but still the same amount for each NORPLANT ® set inserted (LE 20) is distributed to service providers as follows: 3 percent for administrative staff, and the rest is divided among 60 percent for physicians and 40 percent for nurses and Raida Rifia (social workers). 
Percent answering yes
As a following question on who finally made the choice for NORPLANT ® method, the majority of the new users (72%) stated that they themselves made the final choice and another 11% reported that the physician and the woman jointly made the decision. These data indicate that women's informed choice was reasonably upheld (Figure 15 ).
This study also collected information on counseling and information given to clients by service providers before and after NORPLANT ® insertion. Figure 16 shows information given to new users by service providers before the NORPLANT ® insertion procedure. Almost all of the women (96%) reported being told about the use duration of NORPLANT ® (i.e., five years). About two-thirds were told about NORPLANT ® advantages and one-half were told about NORPLANT ® insertion procedures. Counseling on potential side-effects was provided to only 39% of the women. In fact, during client exit interviews, most new users reported that physicians told them "if anything wrong happened, return to the clinic," without specifying the potential side-effects (not shown in the figure) . In addition, only 11% of the new users were told about NORPLANT ® removal procedures before having the implants inserted. This last point indicates a short-coming in the provision of preinsertion information.
All new users were asked to report on follow-up information given to them by service providers after NORPLANT ® insertion (Figure 17 ). The majority reported being told about the need for follow-up visits (92%).
However, only 82%
reported that they received a card including the schedule for follow-up visits. Although the vast majority were told about NORPLANT ® use duration (96%, see Figure   16 ), only about one-fourth of them were told about the due date for removal before they left the clinic.
This is a serious information gap that needs to be emphasized in provider training. Also, only about two-fifths of clients were told that NORPLANT ® could be removed before the due date for removal if needed, and almost the same proportion of women were told about clinics that provide removal The most important advantages and disadvantages of NORPLANT ® as reported by continuing users are shown in Figure 19 . The two most commonly cited advantages to NORPLANT ® use are its long duration (36%) and fewer side effects (24%). In fact some of the continuing users mentioned that they had tried some other family
Principal Advantage
Side-effects 24% planning methods previously, but were not able to tolerate the side-effects. They felt that they had less side-effects with NORPLANT ® or side-effects that were more tolerable (not shown in Figure   19 ). Women who had NORPLANT ® removed before 5 years were also asked about who had made the decision for removal and where did they go to get NORPLANT ® removed. Data in Table 11 show that about two-thirds (62%) of those women reported that the decision was made by themselves, while an additional 29% of women stated that the physician recommended removal. Only a few women (6%) said that their husbands asked them to have NORPLANT ® removed. Table 11 ). About one-third of women in this group (n=45) indicated that the physician who made the insertion couldn't remove the
capsules. An additional one-half of the women said that they were referred to another health facility for removal and about 12% said that the private physician is better (not shown in a table or graph). The majority of women were able to get NORPLANT ® removed through making one visit to the health facility (90%), (Table 11 ). Other women (about one-tenth), however, had to make at least two visits to the health facility to get NORPLANT ® removed. Less than one year 31% 2 -less than 3 19% 4 -less than 5 3% 3 -less than 4 16% 1 -less than 2 31%
Mean duration of use= 1.8 years (up to interview date) Source : home interviews use for 1-2 years (see Figure 21 ). Close to one-third of women reported a duration of 2-4 years of use. Only 3 percent of women reported a period of 4-less than 5 years. This group is approaching the end of effective use duration and will be due for removal shortly. continuers group (see Figure 23) . Among the discontinuers group the most frequently reported sideeffects experienced were severe bleeding (47%), weight changes (39%), menstrual cycle disturbances (35%) and suffering continuous headache (28%). For the continuers group, the most frequently reported side-effects for NORPLANT ® were menstrual cycle disturbance (30%), amenorrhoea (18%), weight changes (17%) and pain at site of insertion (13%) (Figure 23 ).
These types of reported side-effects conform with findings indicated by other studies (Institute of Medicine, 1998 , EFCS, 1995 , National Family Planning Coordinating Board, Indonesia 1993 , Hassan et al, 1992 . 
OVERVIEW OF FINDINGS AND PROGRAM IMPLICATIONS
These study's findings provide comprehensive information on how NORPLANT ® services have been administered and used through the on-going Introduction Program that is now approaching five years of operation.
Major study findings with program implications are highlighted below:
1. The record system audit indicated that about one-third of clients available in clinic registers
were not entered in the central MOHP MIS. The following are possible reasons:
• Clinics ran out of supplies of client information sheets that are completed at the clinic level for women who had NORPLANT ® inserted and sent to the central MIS (monitoring visits during field data collection showed that this could be the case for some clinics).
• Client information sheets may have been completed at clinics and sent to central MIS, but some client information items were missing and the sheets were returned to the clinics for adding the missing information items. Some of these sheets may not have been sent back again to central MIS. 3. Based on the above findings, and keeping in mind the fact that only 56% of women's addresses were complete enough for the field worker to locate, it appears that special mechanisms need to be developed in order to strengthen the capability of NORPLANT ® MIS to identify and locate women eligible for removal.
4. The study also indicated that, although a client follow-up system is in place to inform women who had NORPLANT ® inserted about the schedule of follow-up visits (through giving the woman a card), this system is not completely functional. About 15 percent of the women reported that service providers did not give them a card. Moreover, about two-fifths of the women indicated that they received a card but that it was later lost. Furthermore, if women did not return to clinic for follow-up visits there was no system in place at the clinic to follow up women who failed to make the visits to clinics. The implication of the above findings is that some women eligible for removal might not be reached unless women themselves can remember the due date for removal and seek removal service.
5. The study findings indicated that physicians reported that they need more training on NORPLANT ® insertion and removal (reported by 23 and 53 percent, respectively). Also, physicians reported facing some difficulties during removal, including breaking of rods, incorrect insertion, and difficulties in identifying the exact site of the implanted capsules. These findings call for the need for structured assessment of both the quality of training received as well as physicians' training needs.
6. Women who had NORPLANT ® removed (n= 103) did report difficulties with the removal experience. About two-fifths of those women went to a health facility for removal other than the facility where the NORPLANT ® was inserted. About one-tenth of the women complained that they had to make at least two visits to the clinic to get NORPLANT ® removed. Additionally, one-half of women said that the removal procedure was difficult. Among this latter group, 43% said that they felt pain at the site of capsules and 47% reported too long a removal time.
7. The majority of women who had NORPLANT ® inserted 1-4 years ago (n=624) were comfortable with NORPLANT ® (83%). About 61% of them reported that they will recommend NORPLANT ® to others. The majority of them wanted to terminate childbearing (91%).
According to them, they liked NORPLANT ® because it could be used for five years, its use is associated with fewer side-effects, they do not need to remember to do anything to avoid pregnancy, and it is an effective method. Also, many women (two-fifths) did not perceive any disadvantages for NORPLANT ® . Furthermore, the majority of women who received the method free (about 90%) said that they would pay for the method if requested. However, among this group, the majority of women who discontinued NORPLANT ® use (n=103) were less satisfied with the method. Only 42 percent of this group reported that they were comfortable with NORPLANT ® use and 28 percent said that they will recommend NORPLANT ® to others.
8. Despite overall satisfaction with the NORPLANT ® method, many women reported being worried about side-effects. Experiencing severe bleeding, weight changes, menstrual cycle
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In general, about one-half of women who had NORPLANT ® inserted 1-4 years ago reported facing health problems that they thought were related to NORPLANT ® use. Only about one-half sought medical advice. In one-half of these cases (n=196), the physician gave women medication. It is not known to what extent medication given in such situations has been discussed and/or recommended during training/preparing NORPLANT ® service provision protocols.
9. Irregular supplies of NORPLANT ® capsules seem to occur with implications for free and informed method choice as well as for exposure to unplanned pregnancies. About one-half of physicians said that they face occasional shortages of NORPLANT ® supplies. In this situation, physicians reported that they ask the woman who requested NORPLANT ® insertion to come later when supplies are made available, or they ask her to use another method. Many physicians (42%) said that they give women a temporary method until NORPLANT ® supplies become available.
10. The study findings did not suggest the presence of negative attitudes by service providers toward NORPLANT ® as a family planning method. Physicians insert NORPLANT ® upon request by women when they think that there is no contraindication for NORPLANT ® . It is noted that the study was only conducted in some NORPLANT ® service delivery sites, and the sample of providers is not necessarily representative of all Egyptian physicians and nurses.
11. The study findings indicated that women received partial counseling and information on NORPLANT ® . Only two-fifths of the new users reported being told about side-effects and about one-half said that they were told about insertion procedures. Also, follow-up information given to women after NORPLANT ® insertion was not complete. Only one-fourth of the new users were told about the due date for removal (though almost of them were told that NORPLANT ® use duration is five years), and two-fifths were told about where to go for removal.
12. The findings reflected a lack of consensus among physicians regarding NORPLANT ® contraindication. There also seems to be a need to train providers about the most appropriate candidates for NORPLANT ® use.
13. The study findings indicated that about one-half of women who discontinued NORPLANT ® use had the rods removed before the second year of use. This raises the question of whether those • Promote accessibility to removal services and the quality of these services. As women depend on service providers to both insert and remove the rods, it should be equally easy for women to get NORPLANT ® removed and inserted.
• Develop adequate client follow-up systems. At a minimum, due dates for removal should be carefully observed by clinic staff and clients should be contacted and advised for removal.
• Review the need to ensure regular supplies of NORPLANT ® and the complex nature of the NORPLANT ® service provision system compared with other family planning methods before decisions are made to extend NORPLANT ® services to additional health facilities. Keeping these important issues in mind, appropriate decisions might be taken on whether to expand NORPLANT ® services horizontally through increased number of service delivery units or vertically through continuous quality improvement and increased demand and client satisfaction.
• Develop an integrated quality oriented monitoring and evaluation system for NORPLANT ® service delivery sites.
Tracking and locating NORPLANT ® users
• Develop appropriate mechanisms to promote central MIS capacity to identify and locate women eligible for NORPLANT ® removal. Information items included in clients' records may be minimized to include only basic information needed to track women efficiently to ensure that the rods are removed or replaced when they become no longer effective. The central MIS should be periodically tested for accuracy and completeness of its information. In addition, a decentralized MIS (at the district or clinic level) could be established if the MOHP plans to generate more detailed information regarding the pool of women who seek NORPLANT ® insertion.
• Establish clear guidelines requesting clinic staff to give due attention to recording complete information on women's addresses as well as the address of one of their relatives or neighbors according to instructions currently in place. This would greatly promote efforts to locate women eligible for removal.
Program Sustainability
• Reconsider the decision to provide NORPLANT ® free of charge, in view of the findings on women's readiness to pay for NORPLANT ® among the majority of women who received a free method. A modest user's fee may be introduced as a first step towards making the NORPLANT ® program sustainable.
IEC
• Develop further IEC components that promote women's knowledge about NORPLANT ® as a family planning method. This would help expand contraceptive choice, stress the need to return to clinics to receive follow-up services, and alert women about the need for removal after five years.
